During development, the fetus is exposed to prolactin activity from the placenta, as well as from the developing fetal pituitary. Distinct prolactin receptor isoforms, having different cytoplasmic domains generated by alternative splicing, are expressed as development proceeds at different levels in different organs. The 'long' receptors are able to mediate transduction of all signals examined, in contrast with the 'short' isoforms, whose truncated cytoplasmic domains are able to mediate a much smaller repertoire of signals and can act as dominant negatives. Our studies demonstrate that, although these forms share internalization mechanisms, the long form is internalized faster, resulting in more rapid down-regulation of this form. In order to examine the mechanisms by which prolactin may exert trophic effects on its target tissues during development, we have examined the signalling pathways through which prolactin binding to the long receptor regulates the transcription of cyclin D1. Our studies reveal the importance of the JAK/STAT (Janus
Introduction
In the adult, the pituitary hormones prolactin (PRL) and growth hormone (GH) have classically been associated with many physiological processes, including reproduction, growth, lactation and metabolism. However, more recently, studies of mice with genetic deletions of these ligands or their receptors, supported by analysis of receptor expression, have revealed a role for this family of hormones in fetal development as well [l-31.
During pregnancy, PRL/GH activity in the fetus may be derived not only from the developing fetal pituitary, but also from the products of placentally expressed genes derived from further duplications of the ancestral G H and PRL genes [4] . These proteins share structural features with the pituitary hormones, as well as similar chromosomal genes. In primates, these genes are closely linked to GH, and encode very similar proteins. In contrast, the related placentally expressed genes in rodents and ruminants are more closely related to PRL, and have been shown to be syntenic with PRL in the mouse and cow [5, 6] . These genes have diverged much more from the respective pituitary hormone than those in primates. As part of an effort to understand the action of this family of hormones during pregnancy across species, we have examined the cow as a model system.
Bovine placental PRL-related hormones
P R L radioreceptor assays have facilitated the detection and isolation of placental lactogens (PLs) in many species. In the cow, as in other ruminants, these heterologous radioreceptor assays resulted in the isolation of a single placental protein, bovine PL (bPL) (reviewed in [7, 8] ). Like many placental hormones, including some members of this gene family in other species, bPL is a heterogeneous glycoprotein. These post-translational modifications are likely to alter the biological half-lives as well as the activities of these hormones [9] , presenting an additional challenge in the evaluation of their physiological role.
Low-stringency hybridization to bPRL and related placental cDNAs identified other related transcripts. This diverse subfamily of PRL-related proteins in the cow consists of at least six structurally related secreted glycoproteins [7,10,11], which are not able to bind to PRL or GH receptors (PRLRs and GHRs respectively) [ 121. Although more similar to one another than to other members of this gene family, the amino acid sequences of these proteins are quite distinct from Both bPL and the bovine PRL-related protein subfamily are major products of the binucleate cells of fetal membranes, from very early in pregnancy [8, 12] . These cells are well positioned to secrete into both the fetal and maternal circulations, as well as into the utero-placental environment. In contrast with the distribution of the PLs of several other species, levels of bPL are higher in the fetal than in the maternal circulation ; it is barely detectable in the latter even in late pregnancy (reviewed in [7] ). At mid gestation, fetal bPL levels are similar to those of GH and much higher than those of P R L [ 161. Thus bPL is a major contributor to the total activity of this family of hormones during fetal development.
Bovine PRLRs and GHRs
As in other species, G H R and PRLR transcripts are expressed in a variety of bovine fetal tissues and some in wiwo studies [23, 24] indicates that bPL is a complete agonist at the PRLR, but only a partial agonist at the GHR. Of particular interest is the observation that ovine PL, which is closely related to bPL, can also heterodimerize PRLRs and GHRs, resulting in signal transduction [25] , suggesting yet another way to modulate signalling by this hormone family.
T h e bovine PRLR and G H R are highly similar to these receptors in other species [17,26]. Alternative splicing gives rise to two bovine PRLR isoforms with distinct cytoplasmic domains [27,28], the so-called long (1PRLR) and short (sPRLR) isoforms. Similar to the ovine sPRLR, the bovine sPRLR diverges from the long isoform at the same point in the proximal cytoplasmic domain as in rodents, shortly after the conserved proline-rich region (Boxl), and terminates with a unique 11-amino-acid C-terminal tail [18,27,29]. T h e ability of all short isoforms to transduce signals through characterized PRL signalling pathways is more limited than for the lPRLR, but varies with experimental system [18,3&34]. Furthermore, sPRLR can inhibit lPRLR activation of JAK2 (Janus kinase 2) and transcription via the formation of heterodimers [3 1,3 51.
All target tissues examined so far in both the adult and fetus contain transcripts for both the lPRLR and sPRLR isoforms, the levels of which vary with cell type and physiological status [18,36]. T h e differences in signalling capacity, along with an ability to inhibit signalling via the IPRLR, indicate that the relative levels of these PRLR isoforms is an important determinant of the cellular response to PRL. In contrast with the adult, where some organs such as the liver, corpus luteum and intestine express a predominance of the sPRLR, the bovine mid-gestational fetal liver, spleen and thymus express primarily the lPRLR [181.
PRLR internalization
Internalization is therefore a major modulator of cell responsiveness over the short term. We are only beginning to understand the molecular events regulating these processes for other membrane receptors. Relatively little is known about receptors of the cytokine superfamily. Studies of the GHR, which shares multiple regions of similarity with the PRLR, have demonstrated that it is internalized both by clathrin-coated pits [37] and via caveolae [38] . Furthermore, several approaches have demonstrated that the GHR requires the ubiquitin conjugating system for endocytosis (for a review, see [39] ). PRLR down-regulation in response to ligand in oioo has been described [40] , and internalization has been examined in several in oitro studies [4143] . However, possible differences between the PRLR isoforms in processing and trafficking were not examined.
We have studied the internalization of the long and short isoforms of the PRLR following the binding of PRL and bPL in transiently transfected COS-7 cells. No differences were found in the apparent behaviour of the receptor or in ligand degradation following exposure to these related hormones, further supporting the complete agonist properties of bPL at the PRLR. However, the long and short isoforms of the PRLR were internalized at different rates, the lPRLR more rapidly than sPRLR (57 yo and 33 % respectively internalized at 15 min). In target cells expressing both receptor isoforms, this would result in a relative predominance of sPRLR on the surface after ligand stimulation. The limited ability to 0 200 I Biochemical Society transmit signals, as well as the dominant-negative action of this isoform, suggest that this would lead to a decreased range or an overall attenuation of PRL-induced signals, by lowering the responsiveness of the remaining receptor population.
The pattern of internalization of the bovine lPRLR seen in these studies is comparable with that in previous reports on the rat lPRLR [41] [42] [43] . However, our results differ from those of Vincent et al. [43] , who found that the rat sPRLR was internalized about twice as rapidly as the lPRLR in stably transfected CHO cells. Species differences in receptor sequence may contribute to this difference (discussed below). In order to understand the basis of the differences in the bovine PRLR isoforms, we made successive Cterminal deletions of the IPRLR. No appreciative effect on the rate of internalization occurred until the receptor was truncated after amino acid 311 (cT3 1 l), which caused the rate of internalization to increase significantly (P < 0.05). However, further deletions (truncation after amino acid 272 ; cT272) restored the rate to that of the wild-type IPRLR. This mutant is the same length as the sPRLR, but differs in the final 11 amino acids. Despite the similarity in the sizes of their cytoplasmic domains, the cT272 lPRLR and the wild-type sPRLR differed substantially in their rates of internalization (55% and 33% respectively internalized at 15 min), and were therefore used to define regions important for endocytosis.
Truncation mutations of the rat sPRLR defined two motifs in the cytoplasmic domain that are important for internalization. The first, a dileucine motif at amino acids 259-260, is common to the rat long and short isoforms and is conserved across species [43] . However, the second, a predicted p-turn, is located in the unique C-terminus of the rat sPRLR, and so occurs after the point of divergence of the different isoforms. There is no similar motif in the sequence of the bovine sPRLR, or in two of the three murine short isoforms. However, deletion of the terminal 11 amino acids of the cT272 lPRLR mutant, leaving only sequences common between the lPRLR and the sPRLR, decreased internalization dramatically (38 yo compared with 55 yo). The role of dileucine motifs in the bovine PRLR was examined by mutating each of the three pairs of dileucine residues in the cT272 lPRLR to alanines (I1 2431244, I1 2591260 and I1 2681269; the first two pairs are shared with the sPRLR, whereas the third is unique to the 1PRLR). Mutation of each pair individually reduced internalization signifi-cantly (P < 0.05), consistent with some functional redundancy.
The role of endocytic pathways in PRLR internalization was examined using a dominantnegative mutant of dynamin-1 , a GTP-binding protein known to mediate both the clathrinmediated and calveolar pathways. Overexpression of mutant dynamin-1 (K44E-Dyn-1 [44] ) inhibited the internalization of both isoforms to the level of that of a PRLR with no cytoplasmic domain. In contrast, overexpression of a dominant-negative clathrin hub [45] , specific for internalization via clathrin-coated pits, partially but not completely inhibited this process. These data are consistent with co-precipitation of the rat sPRLR with a-adaptin, a component of an adaptor protein for inclusion in clathrin-coated pits [43] , suggesting that at least some of this receptor isoform is internalized via this pathway.
PRUbPL regulation of cyclin D I expression
PRLR stimulation during development is likely to result in the altered expression of multiple genes in its diverse target cells. However, the trophic effects of PRL and related hormones on many of these tissues suggest that modulation of cell cycle regulators may be an important common effect.
The cyclin D family members are key regulators of progression through G1, and are induced following exposure to many mitogens. Cyclin D1 is expressed in multiple tissues during development, and knockout mice show decreased body size and postnatal viability [46, 47] . The presence of cytokine response elements (GAS sequences) in the cyclin D1 promoter suggested that PRL may exert its trophic effect on developing tissues in part by increasing cyclin D1 transcription via these cisacting elements.
In order to identify PRLR signalling pathways and regulatory sequences, we examined the activity of the proximal 1 kb of the cyclin D1 promoter fused to a luciferase reporter gene in transiently transfected CHO cells expressing the IPRLR. PRL increased cyclin D1 promoter activity by approx. 2-fold in this system. In contrast, PRL had no effect on cyclin D1 promoter activity in CHO cells expressing the sPRLR. The JAK2/STAT 5 (signal transduction and activators of transcription 5) pathway appears to be an essential mediator of PRL activity in this system. PRL induction of cyclin D1 promoter activity was blocked by co-transfection with dominant-negative JAK2. Dominant-negative S T A T 5a decreased both basal and PRL-stimulated activity, whereas co-expression of exogenous wild-type S T A T 5a or 5b augmented stimulation by PRL. Mutation of the distal (-466), but not the proximal (-241), GAS site blocked the action of PRL. However, STATs 1 and 3 also appeared to play roles in the regulation of transcription of cyclin D1, as shown by the results of co-transfection with wild-type and dominantnegative S T A T 1 and 3 constructs. Both S T A T 1 and S T A T 3 dominant-negative constructs partially blocked induction by PRL, whereas additional exogenous wild-type S T A T 3, but not S T A T 1, augmented the PRL response. Consistent with PRL induction of S T A T 5 action at the distal GAS site, PRL induced binding of nuclear proteins to this GAS sequence, as detected by electrophoretic mobility-shift assay. This complex was supershifted with antibodies to both STATs 5a and 5b, but not STATs 1 or 3. In contrast, neither the ~4 2 1 4 4 nor the p38 MAP kinase (mitogen-activated protein kinase) pathways appeared to play a role in PRL activity at this promoter in this assay. PD98059, a specific inhibitor of MEK (MAP kinase kinase), increased basal activity, but did not alter the magnitude of PRL stimulation, and SB203580, a specific inhibitor of p38 MAP kinase, had no effect on either basal or PRL-stimulated activity.
Conclusion
The variety of ligands and the heterogeneity of receptors of the PRL/GH gene family suggest complex roles for these growth factors in fetal development. Elucidation of the activities of the different ligands, the regulation of receptor isoform expression, the processing of these receptors, signalling pathways and tissue-specific target genes will increase our understanding of these processes.
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